The Cooper Companies Inc. (NYSE: COO) has closed the $1.2 billion acquisition of Sauflon Pharmaceuticals Ltd. and a new $700 million loan.
Sauflon, headquartered in Twickenham, England, manufactures and distributes soft contact lenses.
Complete access to real-time information and analysis of news and trends in the industry.
14-Day Free Trial
No credit card required. Complete access to articles, breaking news and industry data.
Have an account? Sign In